Background illustration for clinical trials search

Paid Clinical Trials Greensboro

Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: Deerfield IL, Concord NC, Charlotte NC, Monroe NC,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase2, Recruiting

Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Winston-Salem NC, Chapel Hill NC, Durham NC,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06635785

Phase1, Phase2, Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for
Myelodysplastic Syndromes
Location: Winston-Salem NC, Knoxville TN, Columbia MD, Canton OH,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06499285

Phase3, Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Winston-Salem NC, Charlotte NC, Chattanooga TN,
Sponsor: Incyte Corporation

Sex: Female

Age: 18+

Code: NCT07214779

Phase3, Recruiting

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

for
Non-small Cell Lung Cancer
Location: Winston-Salem NC, Charlotte NC, Huntington WV,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06077760

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Winston-Salem NC, Durham NC, Norfolk VA, Fairfax VA,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase2, Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Winston-Salem NC, Charlotte NC, Norfolk VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase3, Recruiting

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

for
Acute Myeloid Leukemia, in Relapse,
Location: Winston-Salem NC, Charlotte NC, Houston TX
Sponsor: ARCE Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06680752

Phase1, Phase2, Recruiting

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

for
Multiple Myeloma
Location: Winston-Salem NC, Charlotte NC, Spartanburg SC,
Sponsor: Stichting European Myeloma Network

Sex: All

Age: 18+

Code: NCT05028348

Phase3, Recruiting

A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

for
AML, Adult
Location: Winston-Salem NC, Charlotte NC, Houston TX,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18 - 70+

Code: NCT04964518

Phase1, Phase2, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for
AL Amyloidosis
Location: Winston-Salem NC, Durham NC, Mooresville NC,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase3, Recruiting

A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)

for
Septic Shock, Sepsis, Hypovolemia
Location: Winston-Salem NC, Savannah GA, Kansas City MO,
Sponsor: Vivacelle Bio

Sex: All

Age: 18+

Code: NCT06072430

Phase3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Winston-Salem NC, Chapel Hill NC, Charlotte NC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase2, Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

for
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation,
Location: Winston-Salem NC, Lynchburg VA, Midlothian VA,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT04088071

Recruiting

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

for
Liver Neoplasms, Primary Liver Cancer, Secondary Liver Cancer,
Location: Winston-Salem NC, Richmond VA, Gainesville GA,
Sponsor: HistoSonics, Inc.

Sex: All

Age: 22+

Code: NCT06486454

Recruiting

Management of Chronic Pain in Military Patients With Injuries Sustained During Active Duty

for
Extremity Injury
Location: Winston Salem NC
Sponsor: Sceptor Pain Foundation

Sex: All

Age: 18+

Code: NCT01616342

Recruiting

Effects of Graded Protein Intake on Body Composition in Older Adults

for
Sarcopenia
Location: Winston-Salem NC
Sponsor: Wake Forest University

Sex: All

Age: 55 - 70+

Code: NCT04845282

Recruiting

Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab

for
Chronic Lymphocytic Leukemia (CLL),
Location: Winston-Salem NC, Durham NC, Charlotte NC, Boston MA
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07024706

Phase2, Recruiting

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

for
Clostridioides Difficile Infection
Location: Winston-Salem NC, Salisbury NC, Roanoke VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07285213

Phase2, Recruiting

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

for
Severe Asthma
Location: Winston-Salem NC, Gastonia NC, Columbia MD, Rincon GA,
Sponsor: Generate Biomedicines

Sex: All

Age: 12 - 70+

Code: NCT07276724

Phase3, Recruiting